Cowen analyst, Phil Nadeau, reiterated his Outperform rating on shares of Dynavax Technologies (NASDAQ: DVAX) after the FDA voted 12 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE